Search results
Results from the WOW.Com Content Network
John C. Lechleiter (born 1952) is an American businessman and chemist. [ 1 ] [ 2 ] He served as president, chief executive officer, and chairman of the board of directors of Eli Lilly and Company from April 2008 to December 2016.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
After undergoing successful surgery for a dilated aorta on May 13, Eli Lilly Chairman, President, and CEO John Lechleiter has received medical clearance to return to his duties, the company ...
Eli Lilly Chairman, President, and Chief Executive Officer John C. Lechleiter is taking a leave of absence from the company and will be temporarily replaced by Lilly Chief Financial Officer Derica ...
Lechleiter is a surname. Notable people with the surname include: Jakob Lechleiter (born 1911), Swiss politician; John C. Lechleiter (born 1952), American businessman and chemist; Paul Lechleiter, partner in German pianomaker Uebel & Lechleiter; Robert Lechleiter (born 1980), German footballer
John C. Lechleiter was elected as Lilly's CEO and president, effective 1 April 2008. Lechleiter had served as Lilly's president and chief operating officer since October 2005. [234] In July 2016 it was announced that Lechleiter would be retiring. David Ricks was voted to succeed his position. [235]
Investing isn't just buying shares in a hot ticker; it is putting your hard-earned money in the future of a business -- and, often overlooked, trusting management to execute on that vision of success.
In 2012, pharmaceutical executive John C. Lechleiter from Eli Lilly & Company initially proposed the IBRI. [6] [7] In 2013, Indiana governor Mike Pence announced the formation of the IBRI. [8] Pence later worked with life sciences leaders to secure $25 million in startup funds from the state. [9] In 2015, the IBRI hired David Broecker as CEO. [10]